Filing Details
- Accession Number:
- 0001144204-17-044236
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-18 18:48:26
- Reporting Period:
- 2017-08-17
- Filing Date:
- 2017-08-18
- Accepted Time:
- 2017-08-18 18:48:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 727207 | Accelerate Diagnostics Inc | AXDX | Laboratory Analytical Instruments (3826) | 841072256 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1388833 | Lawrence Mehren | C/O Accelerate Diagnostics, Inc. 3950 S. Country Club Road, Suite 470 Tucson AZ 85714 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-08-17 | 223,215 | $22.40 | 762,381 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | $12.49 | 2017-03-18 | 2026-03-18 | 0 | 10,408 | Direct |
| Common Stock | Employee Stock Option (right to buy) | $12.49 | 2026-03-18 | 0 | 60,000 | Direct | |
| Common Stock | Employee Stock Option (right to buy) | $14.92 | 2015-02-26 | 2024-02-26 | 0 | 52,132 | Direct |
| Common Stock | Employee Stock Option (right to buy) | $1.04 | 2022-04-20 | 0 | 2,200,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2026-03-18 | 0 | 10,408 | Direct |
| 2026-03-18 | 0 | 60,000 | Direct |
| 2024-02-26 | 0 | 52,132 | Direct |
| 2022-04-20 | 0 | 2,200,000 | Direct |
Footnotes
- The reporting person contributed AXDX common stock to an exchange fund in exchange for shares of the exchange fund. The AXDX common stock was valued at $22.40 per share for the purposes of determining the number of shares of the exchange fund issuable to the reporting person. The shares were contributed pursuant to a Rule 10b5-1 plan entered into by the reporting person.
- No transaction is being reported at this time. This line is only reporting holdings as of the date hereof.
- The options vest in five (5) equal annual installments on each annivesary of the date of grant beginning on March 18, 2017.
- 580,000 shares vested immediately upon the date of grant (April 20, 2012); 825,000 shares will vest as follows: 40% (330,000 shares) will vest on the second anniversary of the date of grant, and the remaining 60% (495,000 shares) will vest in 36 equal monthly installments (13,750 shares per month) over the subsequent 36 months; and 795,000 shares will vest as follows (provided that both criteria must be satisfied): (i) 40% (318,000 shares) will vest on the second anniversary of the date of grant, and the remaining 60% (477,000 shares) will vest in 36 equal monthly installments (13,250 shares per month) over the subsequent 36 months, and (ii) 50% (397,500 shares) will vest when at least 50% of the warrants initially issued to Abeja have been exercised by the holder(s) thereof, and the remaining 50% (397,500 shares) will vest when at least 90% of such warrants have been exercised by the holder(s) thereof.
Billionaire Hedge Funds
